Cargando…

Improvement of Survival Rate for Patients with Hepatocellular Carcinoma Using Transarterial Chemoembolization in Combination with Three-Dimensional Conformal Radiation Therapy: A Meta-Analysis

BACKGROUND: Transarterial chemoembolization (TACE) has been used alone or in combination with three-dimensional conformal radiation therapy (3DCRT) for treating hepatocellular carcinoma (HCC). The overall survival rate of HCC patients undergoing both treatments, however, has not been systematically...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Houqiao, Gao, Peng, Gao, Hao, Sun, Guangxi, Dong, Chonghai, Han, Jian, Jiang, Guosheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2016
Materias:	Meta-Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915316/ https://www.ncbi.nlm.nih.gov/pubmed/27228411 http://dx.doi.org/10.12659/MSM.895548

Ejemplares similares

What is the best combination treatment with transarterial chemoembolization of unresectable hepatocellular carcinoma? a systematic review and network meta-analysis
por: Xie, Hui, et al.
Publicado: (2017)

Efficacy of three-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus
por: Wu, Fei-Xiang, et al.
Publicado: (2016)

Transcatheter hepatic arterial chemoembolization and sorafenib for hepatocellular carcinoma: a meta-analysis of randomized, double-blind controlled trials
por: Li, Jun, et al.
Publicado: (2017)

Radiofrequency ablation combined with transcatheter arterial chemoembolization therapy versus surgical resection for Barcelona-Clinic Liver Cancer (BCLC) A hepatocellular carcinoma: a meta-analysis
por: Wang, Weidong, et al.
Publicado: (2019)

Three-dimensional versus two-dimensional video-assisted hepatectomy for liver disease: a meta-analysis of clinical data
por: Zhang, Shumao, et al.
Publicado: (2020)

Renal function, complications, and outcomes of a reduction in tumor size after transarterial embolization for renal angiomyolipomas: a meta-analysis
por: Lin, Letao, et al.
Publicado: (2019)

Use of three-dimensional printing in preoperative planning in orthopaedic trauma surgery: A systematic review and meta-analysis
por: Morgan, Catrin, et al.
Publicado: (2020)

MicroRNA-181 as a prognostic biomarker for survival in acute myeloid leukemia: a meta-analysis
por: Guo, Qiang, et al.
Publicado: (2017)

Survival Trends in Sorafenib for Advanced Hepatocellular Carcinoma: A Reconstructed Individual Patient Data Meta-Analysis of Randomized Trials
por: Tan, Darren Jun Hao, et al.
Publicado: (2023)

Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma
por: Kloeckner, Roman, et al.
Publicado: (2015)

Three-dimensional time-of-flight magnetic resonance angiography combined with high resolution T2-weighted imaging in preoperative evaluation of microvascular decompression
por: Liang, Chen, et al.
Publicado: (2022)

Comparative effectiveness of different hepatocellular carcinoma screening intervals or modalities: a systematic review and meta-analysis
por: Yang, Jichun, et al.
Publicado: (2023)

Efficacy of sorafenib in patients with hepatocellular carcinoma after resection: a meta-analysis
por: Shang, Jin, et al.
Publicado: (2017)

Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma
por: Baur, Johannes, et al.
Publicado: (2016)

Meta-analysis of three genome-wide association studies identifies two loci that predict survival and treatment outcome in breast cancer
por: Khan, Sofia, et al.
Publicado: (2017)

Salvage Liver Transplant versus Primary Liver Transplant for Patients with Hepatocellular Carcinoma
por: Yadav, Dipesh Kumar, et al.
Publicado: (2018)

Efficacy of radiofrequency ablation versus laparoscopic liver resection for hepatocellular carcinoma in China: a comprehensive meta-analysis
por: Li, Zhijun, et al.
Publicado: (2021)

Multivariate Analysis of the Predictors of Survival for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Focusing on Superselective Chemoembolization
por: Ji, Suk Kyeong, et al.
Publicado: (2008)

Surrogate endpoint for overall survival in assessment of adjuvant therapies after curative treatment for hepatocellular carcinoma: a re-analysis of meta-analyses of individual patients’ data
por: Huan, Hong-Bo, et al.
Publicado: (2017)

Radioembolization Followed by Transarterial Chemoembolization in Hepatocellular Carcinoma
por: Vardar, Baran U, et al.
Publicado: (2022)

Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma
por: Zhong, Bin-Yan, et al.
Publicado: (2023)

Treatment Response, Survival, and Safety of Transarterial Chemoembolization With CalliSpheres(®) Microspheres Versus Conventional Transarterial Chemoembolization in Hepatocellular Carcinoma: A Meta-Analysis
por: Liang, Bin, et al.
Publicado: (2021)

Combined therapy of transarterial chemoembolization and stereotactic body radiation therapy versus transarterial chemoembolization for ≤5cm hepatocellular carcinoma: Propensity score matching analysis
por: Jun, Baek Gyu, et al.
Publicado: (2018)

Beneficial effects of Cripto-1 for transarterial chemoembolization in hepatocellular carcinoma
por: Li, Xiao-shan, et al.
Publicado: (2019)

Repeated transarterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres vs. conventional transarterial chemoembolization for hepatocellular carcinoma
por: Fukushima, Taito, et al.
Publicado: (2021)

Comparison of the Treatment Response of Drug-Eluting Bead Transarterial Chemoembolization and Conventional Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma
por: Adel, Hatem, et al.
Publicado: (2023)

CD30 expression and survival in extranodal NK/T-cell lymphoma: a systematic review and meta-analysis
por: Chen, Zihang, et al.
Publicado: (2018)

Three-Dimensional Quantitative Tumor Response and Survival Analysis of Hepatocellular Carcinoma Patients Who Failed Initial Transarterial Chemoembolization: Repeat or Switch Treatment?
por: Zhao, Yan, et al.
Publicado: (2022)

Simultaneous transarterial chemoembolization and radiofrequency ablation for large hepatocellular carcinoma
por: Duan, Feng, et al.
Publicado: (2020)

Transarterial chemoembolization extends long-term survival in patients with unresectable hepatocellular carcinoma
por: Kong, Jie-Yu, et al.
Publicado: (2018)

Body Composition Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
por: Parikh, Neehar D., et al.
Publicado: (2018)

Transarterial Chemoembolization related to Good Survival for Selected Patients with advanced Hepatocellular Carcinoma
por: Le, Yong, et al.
Publicado: (2019)

Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma
por: Labeur, Tim A., et al.
Publicado: (2018)

Stage migration as a surrogate of survival in hepatocellular carcinoma treated with transarterial chemoembolization
por: Kassab, Ihab, et al.
Publicado: (2023)

Association of Addition of Ablative Therapy Following Transarterial Chemoembolization With Survival Rates in Patients With Hepatocellular Carcinoma
por: English, Keara, et al.
Publicado: (2020)

Efficacy and Safety of Transarterial Chemoembolization with a Three-Stage Mixed Chemoembolic Regimen for Large Unresectable Hepatocellular Carcinoma
por: Yang, Yanjie, et al.
Publicado: (2023)

The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma
por: Lai, Quirino, et al.
Publicado: (2022)

The Current Practice of Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma
por: Shin, Sung Wook
Publicado: (2009)

Transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma
por: SHAO, WENBO, et al.
Publicado: (2014)

Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma
por: Nam, Hee Chul, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_s4v7t6g986r8c56no02nq36i3b